CTCBIO Inc (060590) — Capital Reinvestment Ratio
CTCBIO Inc (060590) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩5.64 Billion) in capital expenditures (₩212.02 Million). Check CTCBIO Inc (060590) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CTCBIO Inc Capital Reinvestment Ratio (2013–2024)
This chart tracks CTCBIO Inc's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 060590 operating cash flow.
Annual Capital Reinvestment Ratio for CTCBIO Inc (2013–2024)
Year-by-year Capital Reinvestment Ratio for CTCBIO Inc from 2013 to 2024. See cash generation quality of CTCBIO Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩4.50 Billion | ₩2.14 Billion | ▲ +107.4% |
| 2023 | 0.23x | ₩8.22 Billion | ₩1.88 Billion | ▲ +31.8% |
| 2022 | 0.17x | ₩18.22 Billion | ₩3.17 Billion | ▼ -32.8% |
| 2021 | 0.26x | ₩6.46 Billion | ₩1.67 Billion | ▼ -93.1% |
| 2020 | 3.77x | ₩510.09 Million | ₩1.92 Billion | ▲ +185.2% |
| 2019 | 1.32x | ₩1.68 Billion | ₩2.22 Billion | ▼ -90.0% |
| 2017 | 13.22x | ₩295.30 Million | ₩3.90 Billion | ▲ +573.9% |
| 2016 | 1.96x | ₩6.86 Billion | ₩13.46 Billion | ▼ -88.1% |
| 2015 | 16.50x | ₩1.44 Billion | ₩23.71 Billion | ▲ +647.6% |
| 2013 | 2.21x | ₩2.74 Billion | ₩6.05 Billion | — |